Director assumes Clinical Governance and Service Development Roles

Dr. Stephen Davies, Group Medical Director and an Executive Director on the Board of Medica, has announced his retirement and will be succeeded by the company’s current Clinical Director, Dr Robert Lavis. Stephen will work closely with Robert until his planned departure date of 31 May 2021 to ensure an orderly transition.

Dr. Davies, who has led the clinical governance function for Medica since joining in 2013, has transformed delivery of service during his tenure making it a leader in the UK teleradiology market. Influential in the Company’s listing on the London Stock Exchange in 2017, he played a key role in establishing its presence in Ireland following the acquisition of Global Diagnostics Ireland and also in the deployment of Medica’s first augmented intelligence solution.

Dr. Lavis joined the leadership team in September 2020 and has already been influential in driving the clinical aspects of several key strategic projects, along with improvements in clinical protocols associated with trauma and stroke for urgent NightHawk reporting. Prior to joining Medica, Robert worked as a reporting radiologist for the Company for six years. Robert joined Medica from Gloucester Royal Hospital where he is currently a Consultant Radiologist and former Clinical Director. He has extensive experience of clinical practice, starting out his career as a surgeon before entering radiology with a specialist focus on oncology.

Wishing Stephen well on his retirement, Roy Davies, Chairman, said: “On behalf of the Board, I would like to thank Stephen for his dedication and commitment to Medica over the past seven years, as well as his participation as a member of the Board. I look forward to working alongside Robert who shares Stephen’s passion for continuous improvement and his desire to drive change.”